Wordt geladen...
Treatment of COVID‐19 with pentoxifylline: Could it be a potential adjuvant therapy?
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is known for its unique features as an immunomodulatory and anti‐inflammatory agent, also it could have antiviral aff...
Bewaard in:
| Gepubliceerd in: | Dermatol Ther |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300917/ https://ncbi.nlm.nih.gov/pubmed/32473070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13733 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|